Litigation Details for In re: Depomed, Inc. (Fed. Cir. 2015)
✉ Email this page to a colleague
In re: Depomed, Inc. (Fed. Cir. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-12-30 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 6,340,475; 6,723,340 | ||
| Link to Docket | External link to docket | ||
Details for In re: Depomed, Inc. (Fed. Cir. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-04-29 | 30 | involving U.S. Patent No. 6,340,475 B2); and IPR2014-00655 and IPR2014-00656 (involving U.S. Patent No. 6,635,340…IPR2014-00652 Patent 6,723,340 B2 After institution of trial, Patent Owner filed a Patent Owner Response…Pharms. 4 Patent Owner filed a confidential Patent Owner Response (Paper 24) and a public Patent Owner Response…U.S. Patent No. 6,723,340— “Optimal Polymer Mixtures for Gastric Retentive Tablets” (’340 patent)— there…spelled out in the patent. And yet the Board concluded that the ’340 patent was invalid as obvious | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
